Bristol-Myers Squibb Co in Consumer Health

Company Profile

About This Report

Feb 2013

Bristol-Myers Squibb Co, a US-based producer of pharmaceutical and consumer health products, is making increasingly definite steps away from consumer health in order to re-position itself as a bio-pharma player. This has seen sales and share fall in a number of global markets, thanks to a mix of disposals and lack of investment. However, there remain solid opportunities in the product areas and geographies that the company still holds. Whether BMS will pursue these remains to be seen.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Bristol-Myers Squibb Co in Consumer Health

Euromonitor International's report on Bristol-Myers Squibb Co delivers a detailed strategic analysis of the company's business, examining its performance in the Vitamins and Dietary Supplements market and the global economy.

Company and market share data provide a detailed look at the financial position of Bristol-Myers Squibb Co, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Bristol-Myers Squibb Co.

This report examines:
  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWOT analysis of Bristol-Myers Squibb Co provides strategic intelligence on:
  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research You Can Trust:

Euromonitor International's company profile reports are written by our Vitamins and Dietary Supplements research team, a dedicated group of analysts that knows the industry inside and out.

Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Delivery format

Reports are delivered in PDF format and can be downloaded from your online account immediately after purchase.

Scope of the Report

Scope

Strategic Evaluation

Key company facts
Retreat from consumer health seems at hand
SWOT: Bristol-Myers Squibb Co

Competitive Positioning

BMS giving up ground in global consumer health
Divestment and disinterest drive down growth
Consumer health’s stability unlikely to deter further disposals

Market Assessment

BMS disposals weaken presence in more dynamic categories
Western Europe still core, despite problems
BMS analgesics position unfavourable in long term
Moribund French market still BMS’ cornerstone
Brazil a comparative success story

Geographic and Category Opportunities

Global o pportunities hampered by regional sell-offs
Latin America: BMS turns back on a top growth region
Less fragmented offer could, but likely will not, benefit sales
Dynamism of China still offers opportunity, despite recent declines

Brand Strategy

Shrinking portfolio of brands may increase focus
Efferalgan highlights confusing analgesics stance at BMS
Dermodex

Operations

Company overview
Bristol-Myers Squibb: Leading consumer health brands
Research and development

Recommendations

Key takeaways

Report Definitions

Data parameters and report definitions